Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy

Pharmacotherapy
David R P Guay

Abstract

Ibandronate is an experimental intravenous bisphosphonate under study for the prevention or treatment of osteoporosis and skeletal complications of bone metastases, as well as hypercalcemia of malignancy. To review the data on this drug, PubMed/MEDLINE was searched for pertinent studies in English; data from January 1986-October 2005 were reviewed. In preclinical studies, ibandronate was an extremely potent bisphosphonate compared with its predecessors and was active in all animal models of human postmenopausal and corticosteroid-associated osteoporosis. Similar to other bisphosphonates, ibandronate exhibits antitumor activity and prevents or reduces bone metastases. Forty to fifty percent of the dose is bound to bone; renal clearance of unchanged drug accounts for 70% of total body clearance. Early clinical trials demonstrated efficacy and tolerability of intravenous ibandronate in the prevention or treatment of postmenopausal and corticosteroid-associated osteoporosis when administered once every 3 months. Intravenous ibandronate also reduces skeletal complications of bone metastases, including pain, although the cumulative dose used is much higher than that used in osteoporosis, as the drug is administered every 3-4 weeks. S...Continue Reading

References

Sep 1, 1991·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R C MühlbauerH Fleisch
Jan 1, 1993·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·E BlindR Ziegler
Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M PecherstorferD Thiébaud
Jan 1, 1997·British Journal of Cancer·S H RalstonJ J Body
May 1, 1996·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·M PecherstorferJ J Body
Nov 14, 1997·The American Journal of Medicine·D ThiébaudK H Schöter
May 13, 1999·Bone·A GrauerR Ziegler
Jun 4, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R E ColemanJ Kanis
Jun 26, 2001·Journal of the American Society of Nephrology : JASN·Wolfgang GrotzLars Christian Rump
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans D MenssenPierre D Delmas
Jul 10, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Raoul BergnerMichael Uppenkamp
Dec 24, 2002·Prostate Cancer and Prostatic Diseases·A HeidenreichR Hofmann
Mar 19, 2003·Alimentary Pharmacology & Therapeutics·C von TirpitzM Reinshagen
May 15, 2003·The Pharmacogenomics Journal·X Chen, P F Sullivan
Jun 5, 2003·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·M PecherstorferB Bergström
Sep 5, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-J BodyUNKNOWN MF 4265 Study Group
Sep 16, 2003·Annals of the Rheumatic Diseases·J A StakkestadUNKNOWN Ibandronate Intravenous Study Group
Dec 13, 2003·Journal of Endocrinological Investigation·O LamyP Burckhardt
Jan 17, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R R ReckerP J Meunier
Apr 8, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Tim CundyAlan King
Apr 9, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P D DelmasC Christiansen
Jun 16, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·László B TankóClaus Christiansen
Jun 19, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Frieder Bauss, R Graham G Russell
Jul 15, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I J DielUNKNOWN MF 4265 Study Group
Aug 20, 2004·Journal of Clinical Pharmacology·Joanne BarrettSolomon Epstein
Aug 31, 2004·Palliative Medicine·Y SaundersUNKNOWN Steering Group
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Isabelle ManciniJean-Jacques Body
Sep 17, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·M Pecherstorfer, I J Diel
Oct 19, 2004·Seminars in Oncology·Pierfranco Conte, Robert Coleman
Dec 9, 2004·The Breast : Official Journal of the European Society of Mastology·Robert E Coleman
Jan 19, 2005·Anti-cancer Drugs·Frieder Bauss, Jean-Jacques Body
Jun 2, 2005·Journal of Pharmaceutical and Biomedical Analysis·Richard EndeleFrieder Bauss
Aug 2, 2005·Obstetrics and Gynecology
Oct 18, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J D RingeH Faber
Nov 3, 2005·The Oncologist·Roger von Moos
Dec 22, 2005·Journal of Bone and Mineral Metabolism·Johann D RingeParvis Farahmand

❮ Previous
Next ❯

Citations

Nov 23, 2007·Nature Clinical Practice. Nephrology·Kevin W Finkel, John R Foringer
May 26, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E TerposUNKNOWN European Myeloma Network

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.